Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 147,081
  • Shares Outstanding, K 16,452
  • Annual Sales, $ 22,060 K
  • Annual Income, $ -5,390 K
  • 60-Month Beta 1.25
  • Price/Sales 6.27
  • Price/Cash Flow N/A
  • Price/Book 2.21
Trade BWAY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.06
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.22 +23.82%
on 08/30/21
8.99 -0.56%
on 09/24/21
+1.20 (+15.50%)
since 08/24/21
3-Month
7.22 +23.82%
on 08/30/21
10.41 -14.12%
on 06/25/21
-1.39 (-13.46%)
since 06/24/21
52-Week
5.55 +61.08%
on 10/30/20
11.77 -24.02%
on 05/28/21
+3.31 (+58.79%)
since 09/24/20

Most Recent Stories

More News
BrainsWay (BWAY) is in Overbought Territory: What's Next?

BrainsWay (BWAY) has moved higher as of late, but there could definitely be trouble on the horizon for this company

BWAY : 8.94 (+6.43%)
Brainsway Ltd. Sponsored ADR (BWAY) Moves 10.6% Higher: Will This Strength Last?

Brainsway Ltd. Sponsored ADR (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further...

BWAY : 8.94 (+6.43%)
Brainsway Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 20, 2021 / Brainsway Ltd. (NASDAQ:BWAY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 20, 2021 at 8:30 AM Eastern...

BRSYF : 5.5300 (+33.25%)
BWAY : 8.94 (+6.43%)
Should You Buy BrainsWay (BWAY) Ahead of Earnings?

BrainsWay (BWAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BWAY : 8.94 (+6.43%)
STERIS (STE) to Report Q4 Earnings: What's in the Cards?

STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.

COO : 439.38 (+0.01%)
STE : 220.21 (-0.07%)
BWAY : 8.94 (+6.43%)
CNTG : 10.40 (+1.96%)
Strength Seen in Brainsway Ltd. Sponsored ADR (BWAY): Can Its 7.3% Jump Turn into More Strength?

Brainsway Ltd. Sponsored ADR (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could...

BWAY : 8.94 (+6.43%)
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the U.S. Food...

BRSYF : 5.5300 (+33.25%)
BWAY : 8.94 (+6.43%)
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that 100,000 patients...

BRSYF : 5.5300 (+33.25%)
BWAY : 8.94 (+6.43%)
Brainsway Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2021 / Brainsway Ltd. (NASDAQ:BWAY) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 8:30 AM Eastern...

BRSYF : 5.5300 (+33.25%)
BWAY : 8.94 (+6.43%)
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today reported fourth quarter and full...

BRSYF : 5.5300 (+33.25%)
BWAY : 8.94 (+6.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 10.09
2nd Resistance Point 9.54
1st Resistance Point 9.24
Last Price 8.94
1st Support Level 8.39
2nd Support Level 7.84
3rd Support Level 7.54

See More

52-Week High 11.77
Fibonacci 61.8% 9.39
Last Price 8.94
Fibonacci 50% 8.66
Fibonacci 38.2% 7.92
52-Week Low 5.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar